Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial.
Come CE, Divo MJ, San José Estépar R, Sciurba FC, Criner GJ, Marchetti N, Scharf SM, Mosenifar Z, Make BJ, Keller CA, Minai OA, Martinez FJ, Han MK, Reilly JJ, Celli BR, Washko GR; NETT Research Group. Come CE, et al. Respir Med. 2012 Jan;106(1):109-19. doi: 10.1016/j.rmed.2011.07.012. Epub 2011 Aug 16. Respir Med. 2012. PMID: 21843930 Free PMC article. Clinical Trial.
Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M. Tashkin DP, et al. Among authors: martin p, martin uj. Drugs. 2008;68(14):1975-2000. doi: 10.2165/00003495-200868140-00004. Drugs. 2008. PMID: 18778120 Clinical Trial.
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE. Rennard SI, et al. Among authors: martin uj. Drugs. 2009;69(5):549-65. doi: 10.2165/00003495-200969050-00004. Drugs. 2009. PMID: 19368417 Free PMC article. Clinical Trial.
Bronchodilator reversibility in COPD.
Hanania NA, Celli BR, Donohue JF, Martin UJ. Hanania NA, et al. Among authors: martin uj. Chest. 2011 Oct;140(4):1055-1063. doi: 10.1378/chest.10-2974. Chest. 2011. PMID: 21972384 Review.
Longitudinal change in the BODE index predicts mortality in severe emphysema.
Martinez FJ, Han MK, Andrei AC, Wise R, Murray S, Curtis JL, Sternberg A, Criner G, Gay SE, Reilly J, Make B, Ries AL, Sciurba F, Weinmann G, Mosenifar Z, DeCamp M, Fishman AP, Celli BR; National Emphysema Treatment Trial Research Group. Martinez FJ, et al. Am J Respir Crit Care Med. 2008 Sep 1;178(5):491-9. doi: 10.1164/rccm.200709-1383OC. Epub 2008 Jun 5. Am J Respir Crit Care Med. 2008. PMID: 18535255 Free PMC article.
Benralizumab for the Prevention of COPD Exacerbations.
Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. Among authors: martin uj. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.
Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.
Miller BE, Tal-Singer R, Rennard SI, Furtwaengler A, Leidy N, Lowings M, Martin UJ, Martin TR, Merrill DD, Snyder J, Walsh J, Mannino DM. Miller BE, et al. Among authors: martin tr, martin uj. Am J Respir Crit Care Med. 2016 Mar 15;193(6):607-13. doi: 10.1164/rccm.201509-1722PP. Am J Respir Crit Care Med. 2016. PMID: 26745765 Review.
101 results